Name: Low Back Pain: Most Is Non-Specific and Self-Limiting, and It's Badly Over-Treated
Creator: Realised
Published: 2026-06-01

Summary

The everyday model of low back pain — "something is structurally wrong in your spine, get a scan, rest it, and escalate to injections or surgery if it persists" — is backwards for the roughly 90 to 95% of cases that are non-specific (no identifiable structural cause): those are best served by staying active rather than resting, plus exercise, education and reassurance, because routine imaging finds age-normal "degeneration" that is nearly as common in pain-free people (disc degeneration in 37% of asymptomatic 20-year-olds rising to 96% of asymptomatic 80-year-olds) and drives a harmful, eviden

Why Strong

Strong Evidence because the entry's load-bearing claims rest on the highest-grade evidence available for the question: a landmark consortium synthesis (Lancet 2018), a definitive systematic review of asymptomatic imaging prevalence (Brinjikji 2015), current national and specialty guidelines built on systematic review (NICE NG59, ACP 2017), a Cochrane review (stay-active vs bed rest), and RCTs including an adequately powered trial (the fusion-vs-rehab trials). These are primary-endpoint, gold-standard sources with concordant international guidance, not a handful of suggestive studies.

NOT Foundational because the entry carries a genuine live both-ways tension (restraint vs the rare emergency) and clinical/commercial judgement, not a single undisputed axiom.

NOT Moderate for the headline, because the spine — most low back pain is non-specific and self-limiting, imaging finds age-normal changes, stay active over rest, and the over-treatment cascade is unsupported for non-specific pain — is cohort-, RCT- and guideline-backed and robust. The nuances (radicular syndromes that may warrant imaging; fusion's legitimate non-radicular indications) are marked in-entry rather than diluting the headline.

The per-claim read:
• Non-specific majority + over-medicalisation: Strong (Lancet 2018 consortium synthesis).
• Degeneration is age-normal and prevalent in pain-free people: Strong (systematic review, 3,110 asymptomatic).
• No routine imaging, no opioids, active care first: Strong (NICE, ACP guidelines).
• Stay active over bed rest: Strong (Cochrane).
• Fusion not superior to structured non-operative care for non-specific pain: Strong (two RCTs, one powered).
• Favourable natural history with common recurrence: Strong (meta-analysis + recurrence cohorts).
• Red-flag paradox (serious pathology <1%, flags over-triage): Strong (systematic reviews).

Practical takeaway

The framing to hold: almost all back pain is non-specific, real, and self-limiting per episode. The job is to stay active, be reassured, and keep a short danger-sign checklist running — not to chase a scan or a procedure. Restraint is not dismissal.

For non-specific low back pain (the ~90 to 95%):
• Stay active; do not rest in bed. Keep moving within tolerance and return to normal activity as early as you can. Prolonged bed rest is counterproductive.
• Exercise, education and reassurance are the first-line treatment. Almost any exercise you will actually do helps; the modality matters less than staying active and building tolerance. (Loading and core mechanics are owned by core_stability_spinal_health; strength and load tolerance broadly by resistance_training_and_body_composition.)
• Do not seek routine imaging. For non-specific pain with no red flags, an MRI or X-ray does not improve your outcome, and it commonly finds age-normal changes that are frightening and misleading. Ask for imaging only if a red flag is present or a scan would genuinely change the plan.
• Do not treat "degeneration" on a scan as your diagnosis. Disc wear is nearly universal with age and is present in most pain-free older people. It is not a verdict that your spine is broken.
• Expect recurrence, and plan for it. Episodes settle but tend to come back. The durable move is an ongoing activity and load habit, not a one-off "fix." (See physical_counter_modern_postures for the sitting/posture angle.)

On escalation:
• Be sceptical of the cascade for non-specific pain. Opioids are not recommended for chronic back pain; spinal fusion for non-specific pain does not beat structured active/rehab care in trials; injections have limited support for non-specific (non-radicular) pain. These retain legitimate roles for confirmed radiculopathy, instability, deformity or spondylolisthesis — but for non-specific pain, escalation is usually not the answer.

The short red-flag checklist — see a doctor promptly if any are present:
• Saddle anaesthesia (numbness around the groin/buttocks), new bladder or bowel dysfunction, or bilateral leg symptoms → possible cauda equina — this is an emergency, seek urgent care.
• Unexplained weight loss, night pain with systemic symptoms, or a history of cancer → screen for malignancy.
• Fever, or recent infection/IV-drug use → screen for spinal infection.
• Significant trauma, or minor trauma with osteoporosis/long-term steroid use → screen for fracture.
• First onset before age 20 or after age 50, or morning stiffness with a gradual young-adult onset → warrants clinical review (including inflammatory spondyloarthritis).

Evidence detail

Why This Entry Exists

Low back pain is the leading global cause of years lived with disability, and it is one of the most systematically mismanaged conditions in modern medicine — mismanaged, like gout, in two opposite directions at once. The first and larger error is over-medicalisation: the intuitive picture of back pain as a broken part that a scan will reveal and a procedure will fix sends enormous numbers of people into MRIs that find incidental "degeneration," then into rest, opioids, injections and fusion surgery — a cascade the 2018 Lancet series named explicitly as widespread, harmful, evidence-discordant practice. The second error is the over-correction that a debunking entry like this one can accidentally produce: "it's just non-specific, scans are useless, don't worry about it" — which, applied to the rare person with a cauda equina compression or a spinal metastasis, is a catastrophe.

So this entry holds both truths at once, and the both-ways framing is not a rhetorical hedge — it is load-bearing safety design. The mainstream evidence (Lancet 2018, NICE, ACP, Cochrane) genuinely says: for non-specific low back pain, stay active, move, and be reassured; do not routinely image, do not reach for opioids, and do not assume escalation helps. And the same evidence genuinely says: keep a short red-flag screen running, because a small emergency core is real and must not be missed. The message a person with back pain needs is "this is almost certainly non-specific and will settle — stay active, and here is the short list of danger signs that mean see a doctor now." Reassurance is a treatment here, not a brush-off; imaging restraint is pro-patient, not anti-patient. A scan that tells a pain-free 45-year-old they have "degeneration" manufactures fear and sometimes surgery without ever explaining the pain.

What bad advice this protects against, in all directions:
• "You need an MRI to find out what's wrong" → for non-specific back pain, routine imaging does not improve outcomes, finds age-normal changes present in pain-free people, and increases surgery rates without explaining the pain (NICE: do NOT routinely image).
• "Rest your back until it feels better" → bed rest is not therapeutic and is mildly harmful; staying active produces better pain and function outcomes for acute low back pain (Cochrane).
• "The degeneration on your scan is the cause of your pain" → disc degeneration and bulges are nearly as common in asymptomatic people and rise with age regardless of pain; finding them does not establish them as your pain generator.
• "Persistent pain means you should escalate to injections or fusion" → for non-specific low back pain, spinal fusion is not superior to structured non-operative care in RCTs, and opioids are not recommended for chronic back pain.
• "It's just non-specific, so don't worry about any of it" → a small fraction is serious pathology; the red-flag list (saddle anaesthesia, new bladder/bowel change, bilateral leg symptoms, unexplained weight loss, fever, significant trauma) must never be waved away.
• "The pain is in your head / you're catastrophising" → pain is real and biopsychosocial; restraint on scans is triage, not a verdict that the pain is imaginary.
• "Get it fixed once and it's done" → non-specific back pain is self-limiting per episode but recurrence is common (~69% within 12 months), which rewards durable activity habits over chasing a permanent structural fix.

This entry owns the non-specific-vs-red-flag distinction, the imaging-restraint message, the stay-active-not-bed-rest and exercise/education/reassurance first-line, and the honest read on the over-treatment cascade. It defers spinal and core mechanics to core_stability_spinal_health and posture to physical_counter_modern_postures, and it states those boundaries and routes there rather than re-arguing them.

Evidence

Organised from the headline synthesis down through the mechanism, the management, and the red-flag safety net, with the tier signal inline. The spine is Strong Evidence; read the tiers, not just the thesis.

The synthesis — most low back pain is non-specific and the field is over-treated (Strong Evidence).

1. Low back pain is the leading global cause of disability, most of it has no specific identifiable cause, and the condition is over-medicalised. The 2018 Lancet three-paper series by the international low back pain working group synthesised the global evidence and set the current guideline consensus: most low back pain is non-specific and unrelated to any identifiable structural spinal abnormality, and the series explicitly named widespread over-use of imaging, opioids, injections and surgery as harmful, evidence-discordant practice — issuing a "call for action" against exactly that cascade. This is the anchor for the whole entry. (Hartvigsen J, Hancock MJ, Kongsted A, et al. "What low back pain is and why we need to pay attention." Lancet 2018;391:2356–67; Foster NE, Anema JR, Cherkin D, et al. "Prevention and treatment of low back pain." Lancet 2018;391:2368–83; Buchbinder R, van Tulder M, Öberg B, et al. "Low back pain: a call for action." Lancet 2018;391:2384–88. Strong Evidence — landmark consortium series synthesising the global evidence base. Academic authorship, no industry sponsorship; explicitly counter-industry, which raises rather than lowers its credibility on the over-treatment claim.)

Why routine imaging misleads — degeneration is age-normal and prevalent in pain-free people (Strong Evidence).

2. Spinal "degeneration" on MRI is largely age-normal and highly prevalent in people with no pain at all. A systematic review of 33 studies (3,110 asymptomatic individuals) found disc degeneration in 37% of asymptomatic 20-year-olds rising to 96% of asymptomatic 80-year-olds, and disc bulges rising from 30% to 84% across the same age range. Finding degeneration on a scan therefore cannot establish it as the cause of an individual's pain — this is the central mechanistic reason routine imaging drives over-treatment and nocebo (fear manufactured by the finding itself). (Brinjikji W, Luetmer PH, Comstock B, et al. "Systematic literature review of imaging features of spinal degeneration in asymptomatic populations." AJNR Am J Neuroradiol 2015;36(4):811–816. Strong Evidence — the definitive prevalence reference. Neuroradiology-authored and against interest, since it undercuts the diagnostic value of the authors' own modality. Honest counterweight: the companion Brinjikji meta-analysis, AJNR 2015;36:2394, shows degeneration IS somewhat more common in back-pain patients than controls — degeneration is not zero-signal, but its high asymptomatic base rate makes it a poor basis for individual diagnosis or surgery.)

The guideline consensus — no routine imaging, no opioids, active care first (Strong Evidence).

3. National and specialty guidelines converge against routine imaging and opioids and toward active first-line care. NICE guideline NG59 recommends NOT routinely offering imaging for non-specific low back pain (only where it would change management or a red flag is present), NOT offering opioids for chronic low back pain or sciatica, and promoting exercise, self-management, staying active and psychologically-informed care as first-line. The American College of Physicians guideline concurs, recommending non-pharmacological first-line treatment for acute, subacute and chronic low back pain. (NICE Guideline NG59, "Low back pain and sciatica in over 16s: assessment and management," 2016, updated 2020; Qaseem A, Wilt TJ, McLean RM, Forciea MA. "Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians." Ann Intern Med 2017;166:514–530. Strong Evidence — national and specialty-society evidence-based guidelines built on systematic review, with declared-COI processes. The recommendations run directly against opioid manufacturers and imaging/procedure providers, strengthening confidence they reflect evidence, not industry.)

Stay active, don't rest (Strong Evidence, Cochrane).

4. Bed rest is not therapeutic and may be mildly harmful; advice to stay active is the evidence-based instruction. A Cochrane systematic review found that advice to stay active produces small improvements in pain and function versus advice to rest in bed for acute low back pain and sciatica. "Stay active, avoid prolonged bed rest" is the instruction the evidence supports — the intuitive "rest it" is wrong. (Dahm KT, Brurberg KG, Jamtvedt G, Hagen KB. "Advice to rest in bed versus advice to stay active for acute low-back pain and sciatica." Cochrane Database Syst Rev 2010;(6):CD007612. Strong Evidence — Cochrane systematic review, moderate-quality evidence favouring staying active. Non-commercial, methodologically stringent; no industry stake in a "do less, move more" conclusion.)

The over-treatment receipt — fusion is not superior to structured non-operative care (Strong Evidence).

5. Spinal fusion for non-specific chronic low back pain is not superior to structured non-operative care. In an RCT of 64 patients, lumbar instrumented fusion gave outcomes equal to cognitive intervention plus exercises; in the adequately powered MRC spine stabilisation trial (n=349), surgical stabilisation showed no clear benefit over an intensive rehabilitation programme. This is the core receipt that a major, expensive, irreversible intervention is largely unsupported for non-specific low back pain. Fusion retains legitimate indications (instability, deformity, confirmed radicular pathology) — the claim is scoped specifically to non-specific pain. (Brox JI, Sørensen R, Friis A, et al. "Randomized clinical trial of lumbar instrumented fusion and cognitive intervention and exercises in patients with chronic low back pain and disc degeneration." Spine 2003;28:1913–1921; Fairbank J, Frost H, Wilson-MacDonald J, et al. "Randomised controlled trial to compare surgical stabilisation of the lumbar spine with an intensive rehabilitation programme (MRC spine stabilisation trial)." BMJ 2005;330:1233. Strong Evidence — two RCTs, one adequately powered, reinforced by the Lancet 2018 treatment paper's synthesis. Publicly/academically funded; the spinal-device and surgical industry profits from fusion, so these against-industry trials are strong evidence the procedure is over-sold for this indication.)

Self-limiting per episode, but recurrence is common (Strong Evidence) — the honest natural-history nuance.

6. Acute low back pain improves markedly in the first ~6 weeks then plateaus, but recurrence within 12 months is common. A meta-analysis of 33 inception cohorts (11,166 participants) found acute low back pain improves rapidly in the first six weeks and then plateaus; prospective recurrence cohorts find roughly 69% of people have a recurrence of an episode within 12 months. "Self-limiting per episode" does NOT mean one-and-done — it justifies building durable activity and load-tolerance habits rather than chasing a permanent structural "fix." (Menezes Costa L da C, Maher CG, Hancock MJ, et al. "The prognosis of acute and persistent low-back pain: a meta-analysis." CMAJ 2012;184(11):E613–E624; recurrence estimate from da Silva T et al. inception-cohort data on recurrence of low back pain. Strong Evidence — meta-analysis of inception cohorts plus prospective recurrence cohorts. Academic prognosis research (George Institute / Sydney); no commercial stake.)

The red-flag paradox — substantiating BOTH sides at once (Strong Evidence).

7. Serious pathology is under 1% of primary-care low back pain, yet most patients carry at least one guideline "red flag" — so naive red-flag chasing over-triages, while a genuine emergency core must never be missed. Systematic reviews find that serious pathology (fracture, malignancy, infection, cauda equina, axial spondyloarthritis) accounts for well under 1% of primary-care low back pain and non-specific pain for 90 to 95%, yet up to ~80% of patients have at least one red flag present, and most individual red flags have poor diagnostic accuracy in isolation. That is why the answer is judicious clinical-gestalt triage rather than reflexive imaging on every flag — AND why the small genuine-emergency core (e.g. cauda equina: saddle anaesthesia, bladder/bowel change, bilateral sciatica) must still never be missed. The paradox is exactly what makes the both-ways framing evidence-based rather than rhetorical. (Verhagen AP, Downie A, Popal N, et al. "Red flags presented in current low back pain guidelines: a review." Eur Spine J 2016;25:2788–2802; Downie A, Williams CM, Henschke N, et al. "Red flags to screen for malignancy and fracture in patients with low back pain: systematic review." BMJ 2013;347:f7095. Strong Evidence — systematic reviews of red-flag diagnostic accuracy and guideline concordance. Academic, no commercial interest; Downie 2013 notably found most individual red flags have poor accuracy in isolation, supporting gestalt triage over checkbox imaging.)

Mechanism

This entry owns the non-specific-vs-red-flag distinction and the imaging-restraint logic, not the biomechanics of the spine itself. Spinal and core mechanics are deferred in full to core_stability_spinal_health, and posture to physical_counter_modern_postures. What follows is only enough mechanism to make the restraint message and the both-ways safety net intelligible.

Why "find the broken part" fails for non-specific pain. The intuitive model treats back pain as mechanical damage that imaging will localise. But the structures a scan flags as "degenerated" — disc changes, bulges, facet wear — accumulate with age in everyone, and are present in the large majority of pain-free older adults. Because the finding is nearly as common in people without pain, its presence in a person with pain does not establish causation; it is a base-rate trap. The pain in non-specific low back pain is a distributed, biopsychosocial phenomenon (nociception plus sensitisation, load, mood, sleep, fear and context), not a single localisable lesion the scan can point to. That is the mechanistic reason routine imaging misleads: it reliably finds something, and that something is usually an incidental age change, not the cause.

Why the scan itself can make things worse (nocebo). Telling a person their spine shows "degeneration," "wear and tear," or a "bulging disc" installs a mechanical, fragile self-image that increases fear, reduces activity, and predicts worse outcomes. The finding manufactures the fear. This is why imaging restraint is framed as pro-patient: withholding a low-value scan protects the person from a frightening, misleading label and from the escalation cascade it triggers.

Why staying active beats resting. The spine and its supporting tissues tolerate and adapt to load; prolonged rest deconditions them, and fear-driven guarding perpetuates pain. Movement maintains tissue tolerance, down-regulates the threat response, and demonstrates to the nervous system that the back is safe to use — which is why "stay active" outperforms bed rest and why exercise plus reassurance is first-line. The specific mechanics of loading and core function belong to core_stability_spinal_health.

Why the red-flag screen is still essential. A small fraction of back pain is not non-specific: a compressing mass (tumour, epidural abscess, massive disc causing cauda equina), a fracture, or an infection produces pain by a mechanism the "stay active and reassure" model does not address, and delay can cause permanent harm (paralysis, sepsis, neurological loss). The red-flag screen is a low-cost filter that separates the >99% who need reassurance and movement from the <1% who need urgent imaging and intervention. Restraint on imaging for the many is only safe because the screen protects the few.

Risks And Contraindications

• The dangerous failure mode is a reader with a genuine emergency self-dismissing it. This is the load-bearing risk of a "most back pain is nothing, scans are over-used" entry. The both-ways framing and the concrete red-flag list are the safety net and must be foregrounded: saddle anaesthesia, new bladder/bowel dysfunction, or bilateral leg symptoms are a possible cauda equina emergency — seek urgent care now. Likewise unexplained weight loss, fever/IV-drug use, significant trauma or steroid use, night pain with systemic features, or first onset before 20 or after 50 warrant prompt medical assessment. Restraint on imaging applies to non-specific pain with no red flags — never to these.
• Do not over-claim that fusion or injections NEVER help. They retain legitimate indications (confirmed radiculopathy, instability, deformity, spondylolisthesis). The claim is scoped strictly to NON-specific low back pain. Presenting "surgery never works for backs" is the over-correction.
• "Self-limiting" must not be overstated. Roughly 69% recur within 12 months. Frame it as a good per-episode prognosis plus a recurrence-prone course that rewards durable activity habits — not as "one episode and you're cured."
• Restraint is not nihilism. "Don't image, stay active" is an active, evidence-based treatment plan (movement + reassurance + red-flag safety-netting), not "do nothing and ignore it." The pain is real; the plan is real; the scan is what's low-value.
• The pain is never "in your head." Biopsychosocial does not mean psychological-only. Sensitisation, sleep, mood and fear genuinely modulate real nociception. Dismissing the pain as imaginary is both wrong and harmful, and is not what imaging restraint means.
• Keep mechanics and posture out of scope. Loading, core function and spinal mechanics belong to core_stability_spinal_health; sitting and posture to physical_counter_modern_postures. Do not re-argue them here.

Controversy

Nature: a well-evidenced restraint message (most back pain is non-specific; don't image, don't rest, don't escalate) entangled with a stubborn "find-and-fix the broken part" folk model and a large over-treatment industry, with error at both poles — over-treating non-specific pain on one side, and a careless "it's all nothing, scans are useless" nihilism that endangers the rare emergency on the other.

Position A — "Most low back pain is non-specific, self-limiting, and badly over-treated." The mainstream guideline position.
• Best evidence: ~90 to 95% of low back pain is non-specific with no identifiable structural cause; degeneration on MRI is age-normal and prevalent in pain-free people; bed rest is not therapeutic and staying active is better; routine imaging and opioids are recommended against; and fusion for non-specific pain does not beat structured active care in RCTs. Lancet 2018, NICE, ACP, Cochrane and the fusion trials all converge here.
• Where it goes wrong if overstated: it tips into "scans are useless, back pain is always nothing, never worry" — which, applied to a cauda equina or a spinal metastasis, is dangerous.

Position B — "A small fraction is a genuine emergency, and the pain is always real." The safety corrective.
• Best evidence: serious pathology (cauda equina, fracture, cancer, infection, spondyloarthritis) is under 1% of primary-care back pain but must not be missed; radicular/nerve-root syndromes (5 to 10%) may warrant targeted imaging when it would change management; and pain is real and biopsychosocial, never "all in your head." The red-flag paradox (most patients have a flag, but flags have poor accuracy in isolation) supports disciplined triage, not reflexive scanning.
• Where it goes wrong if overstated: naive red-flag chasing over-triages massively, sending the 80% who carry some flag into low-value imaging and escalation — reproducing the over-treatment the evidence warns against.

The funding/bias dimension — cui bono, both ways. Toward over-treatment: imaging centres (per-scan revenue), opioid manufacturers (the 2010s back-pain-driven prescribing boom, now a documented public-health harm), spinal-device makers and surgeons (fusion is a top-revenue elective procedure), and interventional pain clinics (epidural/facet injections) all profit from escalation. Toward restraint: the strongest anchors (Lancet series, NICE, ACP, Cochrane, the fusion RCTs) are authored by independent academics and public bodies with no product to sell and are explicitly counter-industry. The honest reverse-check: the physiotherapy/exercise and CBT/rehab "stay active" world benefits modestly from the first-line message and some of it is commercialised — but its effect sizes are small and openly stated as small, and no comparably powerful commercial machine backs "do less, image less."

Realised Position: Both positions hold simultaneously and are not in conflict. Non-specific low back pain is the default and is best served by staying active, exercise, load tolerance and reassurance rather than scans and passive or interventional treatment; a short, honest red-flag screen protects the rare serious case. The imaging-restraint message is pro-patient, not anti-patient — a scan that finds a pain-free person's age-normal "degeneration" manufactures fear and sometimes surgery without ever explaining the pain. Reassurance is a treatment, not a brush-off, and restraint on imaging and escalation is triage discipline, not dismissal of the patient's pain.

Cross-Pillar Connections

This is a genuinely cross-pillar topic — management spans movement, mental framing (reassurance, fear, nocebo) and evidence literacy, and the condition sits at the crossroads of physical function and the modern imaging/procedure economy.
• Physical (core_stability_spinal_health): owns spinal and core mechanics — loading, core function, the biomechanics of the spine; this entry holds only the non-specific-vs-red-flag distinction, imaging restraint, stay-active-first, and the over-treatment read, and defers the mechanics there.
• Physical (physical_counter_modern_postures): owns posture and the sitting/positional angle; this entry does not re-argue posture and routes there for it.
• Conditions (joint_pain_conservative_management): the sibling conservative-management framing for musculoskeletal pain more broadly — same stay-active, avoid-over-escalation logic applied beyond the back.
• Physical (resistance_training_and_body_composition): why building strength and load tolerance is the durable habit that reduces recurrence-prone non-specific back pain over time.
• Evidence/method (publication_bias_and_evidence_distortion): why the over-treatment cascade persists despite the evidence — the industry-funding and distortion dynamics that keep low-value imaging and procedures in circulation.

What would change our mind

Falsifiability: explicit upgrade/downgrade criteria from source

• We'd upgrade routine imaging or a procedure toward primary care if a large, well-powered, low-risk-of-bias RCT showed that early routine MRI improves patient outcomes (rather than just increasing surgery rates — existing trials show the opposite), or that spinal fusion or epidural injection clearly outperforms structured active/CBT rehabilitation for genuinely NON-specific chronic low back pain (current RCTs show parity).
• We'd legitimise more scanning if a validated imaging biomarker reliably distinguished pain-generating from incidental degeneration — the current problem is precisely that it cannot.
• We'd reweight natural history if a specific structural intervention were shown to prevent the ~69% recurrence better than activity and load habits do.
• We'd harden the red-flag/safety side (not soften restraint) if new data showed current triage misses a materially higher fraction of serious pathology than the <1% base rate implies.
• What would NOT move us: the non-specific-majority finding, the age-normal prevalence of degeneration, stay-active-over-bed-rest, or that recurrent non-specific pain is not fixed by escalation. Across all of it, independent (non-industry) funding is the decisive variable, and the load-bearing claims already have it.

Industry bias note

Structural incentives the evidence base may reflect

Cui bono runs overwhelmingly toward over-treatment, not restraint — and the strongest evidence is conflict-clean.
• The financial incentives all point one way. Imaging centres profit per scan; opioid manufacturers rode the 2010s back-pain prescribing boom (now a documented public-health harm); spinal-device makers and surgeons profit from fusion (one of the highest-revenue elective procedures); interventional pain clinics profit from epidural and facet injections. Escalation is where the money is.
• The restraint evidence is authored against those interests. The Lancet series, NICE NG59, the ACP guideline, the Cochrane review and the fusion RCTs come from independent academics and public bodies with no product to sell, and several are explicitly counter-industry (the Lancet "call for action" names the over-treatment industries directly). This ASYMMETRY strengthens the finding: the conclusion runs against the parties with money to make.
• The honest reverse-check. The physiotherapy/exercise and "reassurance"/CBT-rehab world does benefit modestly from the stay-active message, and some rehab programmes are commercialised. But those effect sizes are small and openly stated as small (not oversold), and no comparably powerful commercial machine backs "do less, image less." The against-interest sources (a neuroradiology group publishing that spinal imaging finds age-normal noise; surgeons' own RCTs showing fusion doesn't beat rehab) are especially credible for cutting against their own field's revenue.
• Net: the evidence base here is unusually clean of the pattern where industry funding manufactures the conclusion. The load-bearing claims are publicly funded and frequently run against the relevant industries — the favourable cui-bono pattern.

Low Back Pain: Most Is Non-Specific and Self-Limiting, and It's Badly Over-Treated